TickerTalks
Browse all tickers →
TickerTalks›$RACC
RARACC

Research Alliance Corporation III Class A Ordinary Shares

$RACC·$138M·Shell Companies·Financial Services
$13.84+4.3%1Y+32.8%
Mentions · last 7 days
2026-07-21: 1 posts2026-07-22: 89 posts2026-07-23: 9 posts2026-07-24: 1 posts2026-07-25: 3 posts2026-07-26: 0 posts2026-07-27: 24 posts127
Price updated 7m ago·X counts updated 23h ago
RARACC
$RACCResearch Alliance Corporation III Class A Ordinary Shares
$13.84+4.26%127 posts
Loading…

What it does

Plain-English summary of the business — what they sell and how they make money.

Research Alliance Corporation III functions as a blank check company, also referred to as a Special Purpose Acquisition Company (SPAC). Its primary objective is to complete a business combination, which might take the form of a merger, an equity exchange, an acquisition of assets or stock, or a corporate reorganization, with one or more other companies. The firm was established on February 19, 2026, and its main offices are located in New York, NY.

Industry overviewAI analysisGenerated by AI from underlying data

Where Shell Companies sits in its cycle right now — and what that implies for $RACC.

Shell Companies · Financial Services

No material change from last week — UMAC's US-based FPV drone goggles and component manufacturing serves defense customers requiring non-Chinese drone supply chains.

Industry benchmark

6-name peer basket
-23.6%YTD
+66.3%1Y

Setup & momentum

Volume, range, and moving-average position — the technical setup driving short-term moves.

Right now

Vol vs 30dToday's traded share volume divided by the average over the prior 30 trading days. ≥3× signals unusual interest; below 1× is quiet.43.1×Today's traded share volume divided by the average over the prior 30 trading days. ≥3× signals unusual interest; below 1× is quiet.
52w rangeWhere the latest close sits between the 52-week low (0%) and high (100%). Above 80% is extended; below 30% is basing or in a downtrend.—Where the latest close sits between the 52-week low (0%) and high (100%). Above 80% is extended; below 30% is basing or in a downtrend.
vs 50d MALatest close vs the 50-day simple moving average. Positive = short-term trend is up.—Latest close vs the 50-day simple moving average. Positive = short-term trend is up.
vs 200d MALatest close vs the 200-day simple moving average. Positive = long-term trend is up.—Latest close vs the 200-day simple moving average. Positive = long-term trend is up.

Float & profile

FloatTiny float · 7.5M shFree-float shares — the slice of issued stock actually available to trade. Lower buckets squeeze harder on a catalyst.Traded today3.8% of floatToday's volume as a percent of the free float. Above 5% on a single day is unusually high turnover for the available share count.β0.005-year weekly beta vs the S&P 500. Above 1.5 means the stock typically moves more than the index; below 0.8 moves less.FilingActive offeringA shelf registration (S-3 / S-3ASR / S-1) or prospectus supplement (424B*) was filed in the last 90 days — the company is registered to (or actively) issuing new shares. Dilution risk.

SEC filings

Material 8-K, 13D, S-3, and 424B5 events from the last 180 days — the filings that actually move the price.

Recent material filings

8-KMaterial agreementJul 278-K — Item 1.01: Material agreement · Item 3.02: Unregistered equity sale · Item 7.01: Press release / Reg FD
SC 13DActivist position (5%+)May 29SC 13D
8-KMaterial agreementMay 218-K — Item 1.01: Material agreement · Item 3.02: Unregistered equity sale · Item 5.02: Officer or director change · Item 5.03: Charter amendment · Item 8.01: Other event
424B4Prospectus supplement (offering)May 20424B4
3New insider — initial holdingsMay 193
3New insider — initial holdingsMay 193
3New insider — initial holdingsMay 193
3New insider — initial holdingsMay 193
+ 15 other (4 13Gs · 2 3s · 2 S-1/As · 1 425) in window

Recent news

Latest headlines from major outlets, sourced and timestamped — context for whatever just moved.

Oak Hill Bio and Research Alliance Corporation III Announce Business Combination Agreement to Create Publicly Listed Rare Disease Biotechnology Company to Advance Antisense Oligonucleotide Therapy Rugonersen for Angelman Syndromeglobenewswire.com·2d ago

More in Shell Companies

Peers in the same group — one click to compare setups, fundamentals, and chatter.

$AFJK$FGMC$BCAR$CCXIW$IPEXR$SIMAU$SPKL
Voices on X · top 1 · last 7 days

TickerTalks is a research tool, not financial advice. We surface social-attention data; we do not make stock recommendations. Past attention is not predictive of future price movements.

PrivacyTermsSupport